RelA and RelB are two members of the NF-kB family that dier structurally and functionally. While RelA is regulated through its cytosolic localization by inhibitor proteins or IkB and not through transcriptional mechanisms, the regulation of RelB is poorly understood. In this study we demonstrate that stimuli (TNF or LPS) lead within minutes to the nuclear translocation of RelA, but require hours to result in the nuclear translocation of RelB. The delayed nuclear translocation of RelB correlates with increases in its protein synthesis which are secondary to increases in RelB gene transcription. RelA is alone sucient to induce RelB gene transcription and to mediate the stimuli-driven increase in RelB transcription. Cloning and characterization of the RelB 5' untranslated gene region indicates that RelB transcription is dependent on a TATA-less promoter containing two NF-kB binding sites. One of the NF-kB sites is primarily involved in the binding of p50 while the other one in the binding and transactivation by RelA and also RelB. Lastly, it is observed that p21, a protein involved in cell cycle control and oncogenesis known to be regulated by NF-kB, is upregulated at the transcriptional level by RelB. Thus, RelB is regulated at least at the level of transcription in a RelA and RelB dependent manner and may exert an important role in p21 regulation. Oncogene (2001) 20, 7722 ± 7733.
Introduction
RelB is a member of the NF-kB family of transcription factors (RelA, c-Rel, NF-kB1 and NF-kB2) which is structurally and functionally dierent from the other two transcriptionally active members, RelA and c-Rel. RelB was cloned as a serum-inducible early gene and shown to possess a Rel homology domain shared by the other NF-kB members (Ruben et al., 1992; Ryseck et al., 1992) . The rest of the RelB gene codes for unique features including an N-terminus containing a leucine zipper-like motif required for full gene transcription and a C-terminus containing a putative acidic transcriptional domain (Dobrzanski et al., 1993) . RelB expression, contrary to that of RelA, is mainly restricted to lymphoid organs, namely the thymus (thymic medulla), spleen, and lymph nodes (deep cortex) (Weih et al., 1994) . RelB, together with p50 and c-Rel, is a major contributor to the constitutive nuclear NF-kB activity observed in lymphoid organs (Lernbecher et al., 1993; Weih et al., 1995) , within mature B cells, plasma cells and interdigitating dendritic cells (Ammon et al., 2000; Carrasco et al., 1993; Liou et al., 1994; Neumann et al., 2000; Pettit et al., 1997) . RelA, on the contrary, is the major component of the inducible pool of NF-kB (Lernbecher et al., 1993) . RelB7/7 mice have absent constitutive nuclear NF-kB activity in the mentioned organs and have multi-focal in¯ammatory in®ltrates of neutrophils and macrophages as well as splenomegaly due to extracellular hematopoiesis (Burkly et al., 1995; Weih et al., 1995 Weih et al., , 1996b . In addition, defective maturation of interdigitating dendritic cells and thymic aplasia have been noted (Burkly et al., 1995) . These defects translate into inecient antigen presentation and ultimately death within a few weeks of birth (Burkly et al., 1995; Pettit et al., 1997; Weih et al., 1995 Weih et al., , 1996b . This contrasts with RelA7/7 mice which are embryonic lethal due to massive apoptosis of the liver (Beg et al., 1995) . The target genes of RelB appear to also dier from those of RelA (Ferreira et al., 1998) . For example, while RelA is an ecient transcriptional activator of IkBa via speci®c cis-acting kB binding sites (Le Bail et al., 1993) , RelB does not result in increased IkBa transcription (Dobrzanski et al., 1994; Weih et al., 1996a) . Conversely, the c-myb enhancer promoter region is transactivated by RelB, but not RelA, via speci®c kB sites, suggesting that at least these two NF-kB transactivating proteins signi®cantly dier also with regard to their transactivating function (Suhasini et al., 1997 , Suhasini ans Pilz, 1999 ).
An additional major dierence between RelB and RelA is their regulation by cytosolic inhibitor proteins. While the latter is sequestered in the cytosol by IkB proteins such as IkBa,b, or e which are targeted by post-translational modi®cations, RelB is not susceptible to their cytosolic inhibition (Dobrzanski et al., 1994; Kistler et al., 1998; Lernbecher et al., 1994) suggesting that RelB may not be regulated by the same post-translational mechanisms targeting RelA. In fact, the few studies addressing RelB expression in models of cell dierentiation and maturation, including B lymphocytes, dendritic cells and macrophages suggest that increased RelB transcription and translation may directly correlate with the degree of nuclear localization (Francis et al., 1998; Kistler et al., 1998; Pettit et al., 1997; Suhasini et al., 1997) . Exogenous stimuli such as serum (Olashaw, 1996) , CD40 activation or LPS treatment of B cells (Neumann et al., 1996) , dexamethasone treatment of T cells (Ivanov et al., 1995) , or increases in intracellular cAMP levels (Suhasini et al., 1997) , all lead to a slow (within hours) increase in RelB mRNA transcripts, protein synthesis and ultimately, nuclear localization (Olashaw, 1996) . This is in stark contrast to the rapid and transcriptionally independent nuclear translocation of RelA. Based on this, it is inferred that the nuclear translocation of RelB may be a function of its synthesis rather than solely post-translational steps, as is generally the case for RelA.
What regulates RelB transcription is unknown, as its promoter ± enhancer region remains to be characterized. However, from the above data it is apparent that immediate early genes may be involved in its transcription, including serum responsive genes, cAMP dependent transcription factors, and potentially NF-kB itself. It has been suggested that RelB synthesis may be reduced in cells with defective NF-kB signaling (Neumann et al., 1996) , raising the hypothesis that RelA may directly transactivate RelB. Precedent exits regarding the ability of the dierent genes of the NF-kB family, or even its inhibitors, to be transcriptionally regulated by the NF-kB members. NF-kB1, NF-kB2, and c-Rel gene transcription is regulated by RelA; and even c-Rel is autoregulated (Hannink and Temin, 1990; Liptay et al., 1994; Ten et al., 1992) . This unique interaction may have functional relevance with regard to the quality and duration of the NF-kB activity in a de®ned cell type following its inducible activation by punctual stimuli. Based on the potential relevance that transcription of the RelB gene may play in its regulation and function, we have sought to characterize the transcriptional regulation of RelB and whether members of the NF-kB family participate in its regulation.
Results

NF-kB inducing stimuli upregulate the transcription and synthesis of RelB
We ®rst investigated whether stimuli known to trigger NF-kB translocation would induce the translocation of the RelB to the nucleus. For this, the presence and levels of the various NF-kB proteins and the levels of the prototype NF-kB inhibitor, IkBa were analysed in both nuclear and cytosolic extracts of the promonocytic cell line U937 following TNF treatment. While RelA and p50 nuclear levels increased rapidly after TNFa treatment (within 30 min), and this was accompanied by a decrease in IkBa in the cytosolic compartment, RelB did not appear in the nucleus even at 2 h after TNF treatment (Figure 1 ). These results suggest that RelB nuclear translocation and its regulation do not parallel that of RelA.
Previous studies have suggested that RelB levels increase within hours after cell stimulation by stimuli known to activate NF-kB such as LPS or CD40 ligation (Neumann et al., 1996) . Based on this, we questioned whether the expected increase in total RelB protein levels in the cell would correlate with de novo translocation to the nucleus. As shown in Figure 2a , lipopolysacharide (LPS) treatment of the B cell line BJAB (left panel) or treatment of the promonocytic cell line U937 with TNF or phorbel esters (PMA) for 6 h (right panel) resulted in a slow but progressive increase in the steady-state level of RelB protein but not RelA (data not shown). We next investigated in BJAB cells whether the increase in the steady state levels of RelB following prolonged LPS stimulation correlated with its nuclear translocation. As shown in Figure 2b (left panel), the increase of RelB in the cytosol following LPS treatment is paralleled by an increase of this transcription factor in the nuclear compartment.
We next reasoned that if the increase in cytosolic RelB following cell activation by stimuli such as LPS or TNF is secondary to transcription, inhibiting gene transcription should decrease RelB increases in the cytosol, and hence its presence in the nuclear compartment. To study this, BJAB cells stimulated for 16 hours with LPS ( Figure 2b Based on the above, it is concluded that RelB protein levels are regulated by transcriptionally dependent mechanisms and that stimuli such as TNF and LPS, known to induce the rapid (transcriptionally independent) nuclear translocation of RelA are involved in regulating RelB transcription and synthesis, which ultimately correlates with its nuclear translocation at later time points than those required for RelA.
RelB transcription is RelA dependent
Based on the above observations, we questioned whether RelB transcription is regulated to some degree by RelA. To address this hypothesis, we studied whether the steady state RNA levels of RelB were increased following cell activation by stimuli known to induce the nuclear translocation of RelA. Both LPS treatment of BJAB (Figure 3a , left panel), or TNF or PMA treatment of U937 wt cells (Figure 3a , middle panel) induced signi®cant increases in the steady state levels of RelB mRNA. Using the U937 cell line that overexpressed a negative dominant isoform of IkBa and which has been previously characterized and described by our laboratory (Asin et al., 1999) , we tested the ability of either TNF or PMA to increase RelB RNA levels. As shown in Figure 3a (right panel), both TNF and PMA resulted in signi®cantly lower RelB RNA levels in the U937 clone expressing the negative dominant IkBa (U937 32A/36A) than in the control U937 clone (U937 wt). This suggests that IkBa is involved in regulating the transcription of RelB, presumably via RelA.
To further explore this possibility, we studied the regulation of RelB in murine embryonic ®broblasts (MEF) derived from the RelA7/7 knockout mouse. TNF stimulation of MEF heterozygous for the RelA deletion (MEF RelA+/7) resulted in an increase in RelB RNA levels ( Figure 3b, left panel) . On the contrary, TNF stimulation of the MEF cells homozygous for the RelA deletion (MEF RelA7/7) did not increase RelB RNA levels ( Figure 3b, right panel) . Moreover, when MEF RelA7/7 are transiently transfected with an expression vector of human RelA, an increase in RelB mRNA levels is observed. This data suggests that RelB regulation is, in part, RelA dependent.
We next investigated whether the eects of RelA on RelB mRNA levels also result in an increase in RelB protein levels, and potentially its nuclear translocation. MEFs from RelA7/7 mice were transiently transfected with a RelA expression vector followed by the analysis of nuclear and cytosolic protein levels. As shown in Figure 3c , transient expression of RelA causes an increase of RelB in the nuclear compartment. Altogether, the data presented thus far argues for a tight regulation of RelB transcription by RelA which in¯uences RelB protein synthesis and ultimately its translocation to the nucleus.
Cloning and sequence characterization of the 5' untranslated genomic region of human RelB
To formally characterize and demonstrate whether RelA-mediated upregulation of RelB mRNA is mediated through direct transactivation of the RelB gene promoter region, we pursued its cloning and sequencing. Using a variety of techniques described in the Material and methods section, a 1694 bp sequence upstream of the translation initiation codon (ATG) was cloned and sequenced ( Figure 4a ). A region with high content of G and C is located approximately 95 bp upstream of the ATG followed upstream by putative NF-kB DNA binding motifs. In addition, CREB and cEBP1 binding cis-acting sequences are noted throughout this 5' region. A TATA consensus motif is absent. Several transcription initiation sites are predicted to emanate from the GC rich region ( Figure  4a ). Using reverse primer extension assays, transcription initiation sites were found at 7114 and 7126 in the region predicted to bind RNA polymerase ( Figure  4a ). Figure 3 RelA increases RelB transcription and protein expression. (a) BJAB cells or U937 wild type cells (wt) expressing empty vector or a vector expressing IkBa 32/32A (U937 32A/36A) were treated with either LPS (5 mg/ml) in the case of BJAB or TNF (10 ng/ml) and PMA (20 ng/ml) for 6 h in the case of U937 cells. Total RNA (10 mg) was extracted and subjected to hybridization with a human RelB cDNA or human GAPDH probe. (b) Mouse embryonic ®broblasts of heterozygous RelA-mice (MEF RelA+/7) or homozygous RelA-mice (MEF RelA7/7) were treated with or without TNF (10 ng/ml) for 4 h. MEF (7/7) cells were also transfected with empty vector (not shown) or vector containing the coding sequence for RelA and harvested 24 h later. Total RNA (1 mg) was analysed by Northern blot hybridization with mouse RelB cDNA or GAPDH DNA 32 Plabeled probes. (c) MEF (RelA7/7) cells were transfected with vector control (vector) or an expression vector coding for the human RelA cDNA. Nuclear extracts (4 mg) or cytosolic extracts (1 mg) were isolated and analysed by SDS ± PAGE and immunoblotted as indicated 
RelA and RelB directly and independently regulate RelB promoter gene transcription
In order to characterize whether this 1694 bp gene region confers basal or inducible transcriptional activity, the DNA between 71694 and 731 (relative to the ATG codon) and which includes the putative transcription initiation sites was cloned into a minimal promoter (pGL-3) driving the transcription of the ®re¯y luciferase gene. Moreover, a number of 5' truncations of the putative RelB promoter regionluciferase expression gene were made (Figure 4a ).
To determine whether the putative RelB promoter is functional, HeLa cells were transiently transfected with the full-length promoter gene (herein referred to as 1.7 kb) or 5' deletions cloned into the pGL-3 basic luciferase expression vector (1.1 kb, 0.6 kb, and 0.25 kb), followed or not by cell stimulation with either TNF or PMA. As shown in Figure 5a , a basal transcriptional activity of the putative RelB promoter enhancer region is detected in the 1.7 kb through 0.6 kb constructs with a decrease observed in the 0.25 kb construct. Moreover, TNF or PMA increased the transcriptional activity of all four RelB promoter gene constructs suggesting that the TNF or PMA responsive cis-acting motifs are located within the 0.25 kb construct.
To determine whether RelA increases the transcription of the RelB promoter gene, constructs 1.1 kb and 0.25 kb were co-transfected with RelA/p50 cDNA into HeLa cells. As shown in Figure 5b , RelA/p50 eectively drives the transcription of either the 1.1 kb or 0.25 kb gene constructs, to a similar degree as that observed for either TNF or PMA. When the same analysis was performed using RelB and p52 cDNA expression vectors, it is demonstrated that RelB in conjunction with p52 is also capable of driving RelB promoter transcriptional activity, albeit to a lesser degree than that observed for RelA/p50. Lastly, it is demonstrated that c-Rel/p50 heterodimers can also drive the expression of RelB promoter enhancer region, albeit weakly (Figure 5b ).
To determine whether RelA or RelB alone are more eective in increasing the transcription of the RelB promoter than when co-transfected with p50, the 1.1 kb construct was co-transfected with RelA or RelB, and/or p50 cDNA into HeLa cells. As shown in Figure  5c , RelA alone is more eective than RelA/p50 in driving the transcription of the 1.1 kb gene construct, whereas RelB alone is less ecient than RelB/p50. Thus, while p50 may exert an inhibitory eect on the promoter activity when expressed with RelA, both RelA alone or RelA/p50 still cause potent transactiva- Figure 5 NF-kB inducing stimuli and RelA, c-Rel, and RelB transcribe the promoter-enhancer region of human RelB. (a) HeLa cells were transiently transfected with a NF-kB concatamer driving the expression of luciferase (kB luc) or the dierent human promoter regions of RelB (1.7 kb through 0.25 kb constructs) plus a TK-luc (Renilla) plasmid to control for transfection eciency. Eighteen hours after transfection cells were stimulated or not with TNF (10 ng/ml) or PMA (20 ng/ml) for 6 h after which cells were lysed. Fire¯y luciferase produced by kB luc or the RelB luc constructs was normalized to the Renilla luciferase activity generated from the TK (thymidine kinase) promoter. The numbers on top of each bar represent (fold) induction over the unstimulated samples in each point. Standard deviations are indicated. (b) Same as in (a) except that 1.1 and .25 kb RelB luc constructs were co-transfected with 2 mg of p50 and RelA or RelB or c-Rel cDNA expression vectors as indicated. Controls were treated with TNF or PMA as in (a). (c) HeLa cells were transfected with 100 ng of the 1.1 kb RelB promoter luciferase reporter construct, 20 ng of a Renilla luciferase reporter construct under the control of a TK promoter, and 100 ng of RelA, RelB, and/or p50. Cells were lysed and luciferase activity was determined by luminescence. Readings are expressed in relative luciferase units (RLU) equivalent to expression of ®re¯y luciferase normalized to the constitutively expressed Renilla luciferase tion of the RelB promoter. Similar results were seen with the 0.25 kb construct (data not shown). Altogether these results indicate that the 5' RelB region, cloned and characterized, confers a basal transcriptional activity; it is inducible by NF-kB inducing stimuli, and more importantly, it is responsive to RelA, c-Rel, and RelB expression.
Based on these results, we next attempted to characterize the putative cis-acting sequences mediating either RelA or RelB dependent RelB promoter activity. As shown in Figure 4 , at least two NF-kB cis-acting motifs are present immediately upstream of the GC rich region and the transcription initiation sites, and are arbitrarily referred to here as kBI and kBII. Individual mutation of these sites within the 1.1 and 0.25 kb construct were performed and the transcriptional activity was analysed as described above. As shown in Figure 6a , mutation of kBI and to a higher degree kBII, abrogates the TNF or PMA-induced transcriptional activation of the 0.25 kb RelB promoter region. If instead of using exogenous stimuli, the RelB promoter ± reporter gene is co-transfected with expression vectors of either RelA or RelB and p50, it is demonstrated that the transcriptional upregulation of the RelB promoter region by RelA or RelB is mediated through kBI or kBII cis-acting motifs.
Activation of the RelB promoter by NF-kB is not cell type specific
To investigate whether or not the RelB promoter activation was cell type speci®c, we transiently transfected the promoter constructs into Jurkat cells (a human T-cell line) and BJAB cells (a human B-cell line). In Jurkat cells, the transcriptional activity of the 1.1 kb and the 0.25 kb RelB-luc expression vectors was increased following TNF and PMA treatment as well as following the transient expression of RelA and RelB, and to a lesser extent of c-Rel (Figure 7a) . Furthermore, mutation of kBI, and to a greater degree, of the kBII cis-acting motif in the 0.25 RelB promoter enhancer region suppressed its transactivation by either TNF or PMA or by the co-expression of RelA, RelB and c-Rel. These results obtained in Jurkat cells con®rm those observed in HeLa cells (Figure 6) .
Using a third cell line, BJAB, it is also demonstrated that LPS induced the promoter activity of the human RelB gene, and is dependent on the presence of both kB cis-acting sites (Figure 7c ).
The kBI and kBII cis-acting sequences present in the RelB promoter bind NF-kB proteins with different affinity
To investigate why the kBII cis-acting is more eective in mediating the transactivation of the RelB promoter by NF-kB proteins or by NF-kB inducing stimuli, we tested whether each kB cis-acting motif may bind with dierent anity the various NF-kB protein members, as suggested by recent studies (Menetski, 2000) . To address this, we performed EMSA in which both cisacting motifs were compared. HeLa cells were transiently transfected with vector alone, or expression vectors for p50, RelA, RelB or c-Rel, and combinations. Nuclear extracts from these transfected cells were then analysed in EMSA using either kBI or kBII as probes. As shown in Figure 8a , kBI binds p50 with greater anity than the kBII site. Likewise, the kBI cis-acting motif binds RelA with a lower anity than the kBII motif. In a repeat experiment the composition of each protein binding complex was further analysed using antibodies against each NF-kB subunit. As Figure 6 The putative cis-acting kB sites present in the human RelB promoter mediate transactivation of the RelB promoter triggered by TNF, PMA, RelA and RelB. (a) HeLa cells were transfected as in Figure 5 with an NF-kB concatamer driving the expression of ®re¯y luciferase or the .25 kb RelB luciferase expression vector (wt), or the same expression vector containing mutations in the kB1 or kB2 sites kB1 or kB2 mut, respectively) plus a TK-luc (Renilla) plasmid to control for transfection. Cells were then stimulated with TNF or PMA as in Figure 5 . (b) Same as in (a) except that the 0.25 kb wt or kB1 mutant or kB2 mutant RelB promoters were co-transfected with expression vectors of p50 and RelA or p50 and RelB shown in Figure 8b , the majority of the NF-kB binding to the kBI motif is composed of p50 homodimers, and to a lesser degree of p50/RelB and p50/c-Rel complexes. In contrast, the kBII motif has a higher anity towards p50/RelA or p50/RelB heterodimers and RelA homodimers. These dierences highlighted through EMSA experiments may explain the higher functional relevance of the kBII motif in mediating the RelA induced transactivation of the RelB promoter activity.
To determine which NF-kB proteins from primary cells would bind the RelB promoter, we performed EMSA with nuclear extracts from human peripheral blood lymphocytes that had been stimulated or not with TNFa ( Figure 8c ). Similar to the HeLa transfection experiments (Figure 8a,b) , the predominant complex from the NF-kB complex present in the nuclei from non-stimulated PBLs binding to the kBI probe appears to be p50 homodimers with very little binding to the kBII probe. However, upon TNFa stimulation, the binding to the kBII probe is increased and composed of p50/RelA heterodimers, while approximately 50% of the complexes bound to kBI are likely p50 homodimers. EMSA was performed on these extracts using an antibody speci®c for RelB and no shift or change in binding was detected for either probe (data not shown). These results again point to the importance of RelA in transactivating the RelB promoter.
RelB drives p21 promoter activity and increases the expression of the p21 protein
Finally, we investigated the potential relevance of RelB in oncogenesis. NF-kB has been known to prevent programmed cell death induced by many dierent stimuli; speci®cally, inhibition of NF-kB has been shown to enhance anti-tumor eects by chemotherapeutics (Wang et al., 1999) . Further, NF-kB has been shown to play a role in the prevention of TNFainduced apoptosis in tumor cells (Beg and Baltimore, 1996) . Since p21 is an anti-apoptotic molecule whose upregulation requires NF-kB in certain cell types (Dotto, 2000; Javelaud et al., 2000; Pennington et al., 2001) , we asked whether RelB, a member of the NF-kB family, plays a role in driving p21 expression. U937 cells, inducibly expressing HA-RelB were treated, or not, for 24 h with cadmium to induce expression of an HA-RelB transgene. As seen in Figure 9a , induction of HA-RelB leads to p21 protein expression. This was observed in a time and dose dependent manner (data not shown). We then questioned whether this RelBdriven increase in protein expression was due to transactivation by RelB on the p21 promoter. HeLa cells were transfected with the full-length p21 promoter luciferase construct, a minimal TK promoter driving Renilla luciferase, and RelB and p50 expression vectors. Cells were lysed and measured for normalized ®re¯y luciferase activity. As seen in Figure 9b , the expression of RelB and its dimer partner p50 promote transactivation of the p21 promoter. Thus, these results provide the ®rst evidence that RelB can regulate the expression of`NF-kB-dependent' genes involved in both cell cycle control and in resistance to apoptosis and thus oncogenesis.
Discussion
This study demonstrates that the regulation of RelB is highly dependent on its transcription which may ultimately in¯uence its translocation to the nucleus Figure 7 The transactivation of the RelB promoter is not cell speci®c. (a) Jurkat T-cells were transfected with the 1.1 kb or 0.25 kb RelB promoter and stimulated or not with TNF or PMA or co-transfected with p50, p52, RelA, RelB or c-Rel expression vectors as in Figure 5 , and analysed as indicated in Figure 5 . (b) Jurkat T cells were treated and analysed as in (A), except that the reporter activity of the 0.25 kb wt and the kBI and kBII mut RelB promoter constructs were analysed. (c) BJAB B cells were transfected with the 0.25 kb wt or the kBI or kBII mut RelB promoter gene and stimulated or not with LPS (5 mg/ml) for 6 h through mechanisms that dier from those regulating RelA. Our studies lead to the conclusion that the RelB gene is susceptible to the transcriptional activity of RelA, as well as that of RelB, and to a lesser degree of c-Rel. The ability of NF-kB members to regulate RelB transcription is dependent on speci®c kB sites; one of which is the main target of both RelA and RelB, as well as of stimuli that lead to RelA nuclear translocation such as TNF or LPS.
While the focus of the present study was to characterize the transcriptional regulation of RelB, it was important to address whether dierences exist between RelA and RelB with regard to their regulation, i.e., post-translational mechanisms. Our initial results indicate that at least in two dierent cell types, NF-kB inducing stimuli such as TNF or LPS induce a rapid nuclear translocation of RelA, but require hours to result in RelB nuclear translocation. The latter (a) and nuclear extracts were incubated with g-32 P-labeled BI or BII DNA probes in the presence or absence of antibodies speci®c for p50, RelA, RelB, or c-Rel. The complexes were analysed by EMSA. Densitometry was performed and the percentage of complex shifted or inhibited from forming by the speci®c antibody is indicated. (c) Human peripheral blood lymphocytes were stimulated or not with TNFa (10 ng/ml) for 20 min. Nuclear extracts were incubated with g-32 P-labeled kBI or kBII DNA probes in the presence or absence of antibodies speci®c for p50 or RelA. The complexes were analysed as above (B) parallels increases in its protein and RNA synthesis, both of which can be aborted by shutting o gene transcription. Such ®ndings support the concept that RelB regulation, dierent from that of RelA, is more dependent on inducible gene transcription than in posttranslational regulation to in¯uence its cellular sublocalization. This, however, does not exclude that once RelB transcription and translation are induced the newly synthesized RelB is not anchored in the cytosol by a speci®c inhibitor which, if it exists, appears to dier from IkBa. Future studies should address this possibility.
The formal demonstration that RelA is an eective transactivator of RelB helps to clarify multiple observations indicating that stimuli, which lead to a rapid and transient increase in nuclear RelA, also lead to a later and more long-term presence of nuclear RelB (Neumann et al., 1996; Olashaw, 1996) . The functional relevance of this sequential and coordinated event remains unknown but may be extremely useful in certain biological processes. For example, B-cell, macrophage, or dendritic cell dierentiation are characterized by a sequential activation of NF-kB family members. While RelA is usually present initially, as the cell becomes dierentiated or undergoes maturation, RelB becomes a major component of the constitutive pool of NF-kB present in the nuclei of such cells (Francis et al., 1998; Kistler et al., 1998; Pettit et al., 1997; Suhasini et al., 1997) . The novel regulatory feature identi®ed in this study for RelB could also explain how RelB, once it is initially transcribed in a RelA dependent manner, is then constitutively autoregulated in a transcriptionally dependent manner. As RelB has been shown to be poorly, if at all, controlled by conventional IkB proteins, increased transcription ultimately will lead to increased protein synthesis and nuclear translocation. Therefore suggesting that RelB transcription is a major factor in the regulation of this transcription factor.
While a number of examples have surfaced indicating that RelA and RelB dier in their ability to transcribe kB containing cis-acting genes, in the case of the kB sites present within the RelB gene, both transcription factors are independently able to transactivate it. We speculate that this situation will facilitate the initiation and constitutive transcription of RelB in cells of lymphoid and myeloid origin. Also, the relevance of having two consensus kB cis-acting sequences present in the promoter-enhancer of the RelB gene is unclear. Our studies demonstrate that while both are functional, signi®cant dierences are observed with regard to their ability in mediating the transactivating activity of RelA, RelB, or stimuli known to induce NF-kB translocation such as LPS or TNF. In fact, our ®ndings resemble those previously described by our group for the promoter-enhancer region of the NF-kB1 gene promoter (Ten et al., 1992) . However, in the case of RelB, a signi®cant dierence is observed with regard to the kBII site as it binds with higher anity heterodimers of RelA or RelB as compared to the kBI site which preferentially binds p50 homodimers with higher anity than RelA or RelB heterodimers. Such dierences are in part supported by recent studies demonstrating that the nucleotide sequence of the kB binding site can predict its ability to bind RelA heterodimers versus p50 homodimers (Menetski, 2000) . The functional dierences conferred by these two kB sites is exempli®ed by the ability of the kBII site to be indispensable to mediate the transactivation function of TNF, LPS, PMA or of co-transfected RelA or RelB.
While the present study was initially designed to address the role of RelA in the transcriptional regulation of RelB, the cloning and characterization of a large genomic region containing the RelB promoter will enable future studies to characterize the putative role of NF-kB-unrelated transcription factors. The initiation of the coordinated and complex process of either B-cell, dendritic cell, or macrophage dierentiation ultimately leads to signi®cant increases in RelB transcription, protein synthesis and constitutive nuclear translocation. While RelA may play a role in Figure 9 RelB drives the expression of p21 protein and p21 promoter activity. (a) U937 cells were stably expressing a cadmium inducible HA-RelB transgene. Cells were treated with or without 90 mM cadmium for 24 h to induce or not HA-RelB, as indicated above the ®gure. 20 mg cytosolic lysates were subjected to SDS ± PAGE. Membranes were blotted with anti-HA and anti-p21 antibodies. (b) HeLa cells were transfected with 100 ng of a full-length p21 promoter-®re¯y luciferase reporter construct and 50 ng of a TK-Renilla luciferase reporter construct with or without 100 ng of RelB and 100 ng of p50 cDNA. Cells were lysed and luciferase activity was determined by luminescence. Readings are expressed in relative luciferase units (RLU) equivalent to expression of ®re¯y luciferase normalized to the constitutively expressed Renilla luciferase this process, other transcription factors may ultimately also trigger and regulate RelB transcription. The fact that dexamethasone or c-AMP increasing agents lead to RelB transcription (Ivanov et al., 1995; Suhasini et al., 1997) suggests that transcription factors such as CREB which are present scattered throughout the enhancer region may also be involved in RelB transcription under dierent circumstances.
Due to the apparent relevance that gene transcription plays in in¯uencing RelB nuclear localization and its potential perpetuation in the nuclear compartment, results presented in this study will be useful to further characterize the role that RelB plays in the immune system and in disease processes such as lymphoid malignancies. As a ®rst step in understanding RelB's role in potentially preventing apoptosis and facilitating tumorigenesis, we have shown that p21, a known apoptosis antagonist (Asada et al., 1999; Javelaud et al., 2000; Jiang and Porter, 1998; Pennington et al., 2001) , is regulated by RelB. This information, along with published data concerning RelB's ability to stabilize the c-myb oncogene at the transcriptional level (Suhasini and Pilz, 1999; Suhasini et al., 1997) , gives RelB an important role in the ®eld of apoptosis.
Material and methods
Reagents, antibodies, and cell culture
Recombinant human tumor necrosis factor a (TNF) was obtained bry Genzyme (Cambridge, MA, USA). Actinomycin D, Lipopolysaccharide (LPS) from Pseudomonas aeruginosa and phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Antibodies to RelB, RelA (p65), c-Rel, p50, p52, IkBa, and b-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The p21 antibody was purchased from Transduction Laboratories (San Diego, CA, USA). The RelB antibody used in the electromobility shift assay was a kind gift from Dr Nancy Rice (National Cancer Institute, Frederick, MD, USA). The human histiocytic cell line U937 was obtained from the ATCC. The 32/36 mutant U937 cell line is a clone derived by stably expressing an IkBa gene with serines 32 and 36 mutated to alanine and, together with its corresponding control have been previously published (Asin et al., 1999) . U937 cells were maintained in RPMI 1640 (Biowhitaker) plus 5% fetal bovine serum (Intergen). HeLa cells were obtained from ATCC and maintained in DMEM (Life Technologies) plus 10% fetal bovine serum. Jurkat T cells and BJAB B cells were maintained in RPMI 1640 plus 5% or 10% fetal bovine serum, respectively. The mouse embryonic ®broblasts (MEF) (p657/+) and (p657/7) were a generous gift from Dr Amer Beg (Beg et al., 1995) (Columbia University) and were maintained in DMEM plus 10% fetal bovine serum. Peripheral blood lymphocytes were harvested from human buy coats by removing the adherent population. The nonadherent fraction was then cultured for two days at 2610 6 / ml RPMI 1640 plus 10% FBS before stimulating with TNFa.
In order to generate stable clones which inducible express RelB, HA-RelB was subcloned into a eukaryotic expression vector under the control of the metallothionein promotor (pMEP4; Invitrogen). HA-RelB/pMEP4 was electroporated into U937 clones stably and clones were isolated by limited dilution. Expression of the transgene was induced by treatment of the cells with 90 micromolar CdCl 2 for 24 h and leads to expression in 490% of cells by immunouoresence.
Plasmids and gene transfections
The plasmids p50, p52, RelA, c-Rel, and RelB were created by cloning the corresponding human cDNA sequence into the mammalian expression vector pcDNA3 (Invitrogen). p21 promoter-luciferase was a generous gift from Dr Wa®k ElDeiry from the University of Pennsylvania. Transfections were carried out using FuGene6 reagent (Roche Biochemicals) in accordance with the manufacturer's instructions. Transfected cells were harvested 18 to 24 h post-transfection.
Nuclear and cytosolic protein preparation and Western blotting
Nuclear and cytosolic proteins were prepared using a modi®cation of the method of Dignam (Dignam et al., 1983) . Brie¯y, cells were washed with cold buer A (10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 4 mg/ml aprotinin, 2 mg/ml leupeptin, 0.8 mg/ml pepstatin, 0.5 mM DTT, and 1 mM phenylnethylsulfonyl¯uoride) and lysed in buer A plus 0.1% NP-40 for 5 min on ice. The cytosolic fraction was harvested by centrifuging the lysate at 4500 r.d.f. for 3 min and collecting the supernantant. The nuclear pellet was washed twice with buer A (centrifuging at 4500 r.d.f. for 3 min each time). The nuclear proteins were extracted by resuspending the pellet in 20 mM HEPES pH 7.9, 042M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, DTT and protease inhibitors as in buer A, plus 25% glycerol for 30 min on ice. Nuclear and cytosolic proteins were electrophoreses on 10% SDS polyacrylamide gels and electro-transferred to Immobilon-P membranes (Millipore). Standard methods were used for the antibody detection and the signal was developed with ECL (Amersham).
RNA extraction and Northern blot analysis
The total RNA was isolated by the RNAzol B method (TelTest Inc.) . Fifteen mg of denatured RNA was electrophoresed on a 1% agarose/formaldehyde gel, transferred to nylon membrane (Hydong N+, Amersham) by capillary action, and ®xed by UV crosslinking. The membranes were incubated in Rapid-Hyb buer (Amersham) containing a 32 P-labeled probe at 658 C. After hybridization the membranes were washed twice in 26SSC at room temperature, twice in 16SSC plus 0.2% SDS at room temperature, and once in 16SSC plus 0.1% SDS at 658C. The membranes were then exposed to X-ray ®lm for autoradiography. The mouse RelB probe used was a PCR product corresponding to bases 340 and 1206 of the mouse RelB gene. The human RelB probe used was a PCR product corresponding to bases 265 to 1416 of the human RelB gene. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe used corresponds to the full-length human sequence.
Isolation and sequence of the 5' untranslated RelB promoter ± enhancer region Two nested antisense primers (RelB GSP11 5'-TCTGCCCA-TTGCTCTGGACGAGACA-3' RelB GSP12 5'-GGATCGA-GAGGTTGGCAGGGCTCTA-3') were chosen from the IRel exon 1 sequence (Accession #AF043454) at NCBI. 5' RACE reactions were carried out using the CLONTECH Promoter Finder DNA Walking Kit as per the manufac-turer's instructions. The result of these reactions was a single product of 150 base pairs in length in only one of the ®ve libraries. This product yielded approximately 75 bases of 5' sequence from which two more nested, antisense primers were made (RelB GSP13 5'-CTCCAAGGTCTCGCTACACCT-GAGT-3', RelB GSP14 5' TCAACCGTAAATTGAGGAT-GAAGAT-3'). 5' RACE reactions were again performed and yielded approximately a 1.2 kb single product in only one library. A sense primer (RelB prom FL 5'-GGGTACCATT-TGTGTGACCTTGGAGAAATT-3') with a 5' KpnI site was made to the sequence near the 5' terminus of the 1.2 kb fragment. This primer together with an antisense primer (RelB prom AS 5'-CGAGATCTACGGTCTGGTGGAC-GAT-3') with a 5' BglII site corresponding to the sequence approximately 30 bases 5' from the RelB`ATG' were used to PCR a 1.7 kb product from U937 genomic DNA which was then cloned into pGEM T-easy (Promega). Sequencing of this 1.7 kb product and comparison with the known RelB 5' sequence con®rmed it to be a continuation of the RelB 5' sequence ( Figure 3a) .
Digestion of the 1.7 kb 5' product with KpnI and BglII, SacI and BglII, NheI and BglII, and MluI and BglII yielded products of 1.7 kb, 1.1 kb, 0.6 kb and 0.25 kb, respectively, which were cloned into the pGL3 basic vector (Promega) (Figure 3b) . These constructs were then used to test for promoter activity in the region upstream from the RelB gene sequence.
Two NF-kB sites were identi®ed by the MatInspector software at TRANSFAC. NF-kBI (GGGGTTTTCC) is located at 7247 to 7238 and NF-kBII (GGGGAATTCC) at 7175 to 7166 relative to the RelB`ATG.' The NF-kBI site was mutated by PCR using a sense primer (RelB mut kBI 5'-GACGCGTGCTCCTTTTCCCGTTCCC-3') which straddles the NF-kBI site and the antisense primer RelB prom AS. The PCR product was cloned into pGEM T-easy and then digested out with MluI and BglII and cloned into pGL3 basic. This mutated the NF-kBI site to CTCCTTTTCC, a mutation that has been previously shown to block NF-kB transactivation (Ten et al., 1992) . NF-kBII was mutated by making two mutated overlapping primers (RelB mut kB2(s) 5'-GCCCTTCAATTCCGCCGCCC-3'; RelB mut kBII (AS) 5'-GAATTGAAGGGCGCCGCCGGC-3' both of which straddle the NF-kBII site. PCR reaction 1 was performed using a sense primer corresponding to a sequence 5' from the MluI site and primer RelB mut kBII (AS). PCR reaction two was performed using primer RelB mut kBII(s) and primer RelB prom (AS). PCR reaction two was performed using primer RelB mut kBII(s) and primer RelB (AS). The overlapping products from reactions 1 and 2 were then gel puri®ed and put back into a PCR reaction with the primer 5' to the MluI site and primer RelB prom (AS). This ®nal product was cloned into pGEM T-easy and digested out with MluI and BglII and cloned into gGL3 basic. This resulted in a mutation of the NF-kBII site to CTTCAATTCC. Both mutations with surrounding sequence were run through the MatInspector software to insure that the mutations did not create new transcription factor binding sites. Neither of the mutations created a known transactivating site.
RelB promoter functional analysis
HeLa cells were seeded in 24 well plates at approximately 50% con¯uency. Twenty-four hours later they were transfected with 100 ng of promoter construct in pGL3-Basic (Promega) plus 2.5 ng of pRL-TK plasmid (Promega) encoding Renilla luciferase under the thymidine kinase (TK) promoter. To test for response to NF-kB, RelA or RelB or cRel plus p50 or p52 were expressed by transfecting 50 ng of each construct in pcDNA3 vector (Invitogen) along with the promoter constructs. Eighteen hours later the cell lysates were assayed with the Dual-Luciferase Assay Kit (Promega) according to the manufacturer's directions. Jurkat cells and BJAB cells were transfected by electroporation (Electro Square Porator, BTX) maintaining similar plasmid/cell ratios.
Electromobility shift assay
Nuclear proteins were tested for binding to NF-kB cis-acting motifs in the electromobility shift assays (EMSA) as previously described (McElhinny et al., 1995) . The NF-kB probes I and II were made by annealing complimentary 18 base oligonucleotides which straddle the NF-kBI or NF-kBII sites present in the RelB promoter-enhancer region, respectively. The double-stranded probes were then labeled with g-32 P ATP and polynucleotide kinase (Roche, Indianapolis, IN, USA).
Densitometry
Densitometry of Western blots and EMSA was performed using the AMBIS Image Analysis System (AMBIS Inc., San Diego, CA, USA). Western blot quanti®cation was expressed relative to a b-actin control protein. EMSA quanti®cation was expressed as a percentage of a non-stimulated or noncompeted lane.
